Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Cardiac AI Monitoring and Diagnostics Market, The Global Cardiac AI Monitoring and Diagnostics Market size is estimated to grow at a CAGR of around 25.6% during the forecast period, i.e., 2024–30. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight & sustainable materials, rising demand for luxury & customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Cardiac AI Monitoring and Diagnostics Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

• Forecast Period: 2024-2030
• CAGR (2024-2030): 25.6%

Key Perks: “In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/cardiac-ai-monitoring-diagnostics-market.html

Global Cardiac AI Monitoring and Diagnostics Market Segmentation Breakdown:

The Cardiac AI Monitoring and Diagnostics Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic.  The further bifurcations are as follows:

• By Product
  • Software- Market Size & Forecast 2019-2030, USD Million
  • Hardware- Market Size & Forecast 2019-2030, USD Million
• By Type
  • Cardiac Diagnostics- Market Size & Forecast 2019-2030, USD Million
    • Cardiac Imaging- Market Size & Forecast 2019-2030, USD Million
    • Electrocardiography-Based (ECG-Based) Diagnostics- Market Size & Forecast 2019-2030, USD Million
    • Others (Blood Biomarker Analysis, Cardiac Stress Testing, etc.) - Market Size & Forecast 2019-2030, USD Million
  • Cardiac Monitoring- Market Size & Forecast 2019-2030, USD Million

Cardiac diagnostics has been dominating the Global Cardiac AI Monitoring and Diagnostics Market over the past few years.

• By Indication
  • Hypertension (High Blood Pressure)- Market Size & Forecast 2019-2030, USD Million
  • Coronary Artery Disease (CAD)- Market Size & Forecast 2019-2030, USD Million
  • Arrhythmias- Market Size & Forecast 2019-2030, USD Million
  • Cardiomyopathies- Market Size & Forecast 2019-2030, USD Million
  • Others (Valvular Heart Disease, Peripheral Artery Disease (PAD), etc.) - Market Size & Forecast 2019-2030, USD Million
• By End-User
  • Hospitals - Market Size & Forecast 2019-2030, USD Million
  • Diagnostic Centers- Market Size & Forecast 2019-2030, USD Million
  • Specialty Cardiology Clinics- Market Size & Forecast 2019-2030, USD Million
  • Ambulatory Surgical Centers- Market Size & Forecast 2019-2030, USD Million

Among them, the hospital segment dominated the Global Cardiac AI Monitoring and Diagnostics Market, claiming the majority of the market share.

Geographical Growth Insights:

• By Region
  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Among all of them, North America acquired the largest market share in the Global Cardiac AI Monitoring and Diagnostics Market.

MarkNtel Advisors Highlights Key Market Drivers for Cardiac AI Monitoring and Diagnostics Market:

Rising Incidence of Coronary Artery Diseases – With the rising incidence of coronary artery diseases worldwide, especially across Asia-Pacific, and Europe, owing to the rising adoption of unhealthy and sedentary lifestyles among consumers, demand for monitoring and diagnosis services has been increasing significantly across the globe. Additionally, other health factors, including physical inactivity, being overweight, unhealthy eating, and smoking tobacco, have been causing the deposition of plaque and cholesterol in blood vessels, causing cardiovascular diseases (CVD). For instance,

• According to the British Heart Foundation, in 2022, globally, 1 in every 14 people was living with coronary heart disease, either linked to the heart or circulatory vessels.

Consequently, as the number of patients suffering from CVD has been increasing, healthcare professionals have started inclining toward AI software and services over the years. The inclination toward AI software in cardiovascular diagnosis and monitoring has been attributed to the ease of processing large amounts of data generated from these diagnostic devices within a minimum amount of time. Henceforth, with the rising number of heart diseases, coupled with growing health facilities adopting AI software in the cardiology segment across regions like North America, Asia Pacific, etc., the market would witness considerable growth & expansion during the forecast period.

A Comprehensive Analysis of Leading Companies in Global Cardiac AI Monitoring and Diagnostics Market

• HeartVista, Inc.
• Siemens Healthineers AG
• RSIP Vision
• Ultromics Limited.
• Tempus Labs, Inc.
• Cardiologs Technologies
• Cleerly, Inc.
• AliveCor, Inc.
• Aidoc Medical Ltd.
• Boston Scientific Corporation
• CathWork Inc.
• HeartFlow, Inc.
• iRhythm Technologies, Inc.
• Nano-x Imaging Ltd.
• Others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/cardiac-ai-monitoring-diagnostics-market.html

Cardiac AI Monitoring and Diagnostics Industry Recent Developments

• 2023: Ultromics Limited, introduced EchoGo® Heart Failure, an AI solution for echocardiography, which has achieved clearance from the US Food and Drug Administration (FDA). EchoGo® Heart Failure is an AI-powered platform designed for precise identification of heart failure with preserved ejection fraction (HFpEF).
• 2022: iRhythm Technologies, Inc., received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System designed for the Zio Watch. Developed in partnership with Verily, an Alphabet precision health company, the ZEUS System combines advanced deep learning algorithms with a trusted cardiac arrhythmia service.

What are the growth Opportunity driving the Global Cardiac AI Monitoring and Diagnostics Market?

Increasing Focus on the Development of AI-Enabled Implantable Cardiac Monitors – In recent years, several companies in the medical device segment have started focusing on the development of implantable cardiac monitors, which are operated through AI software. Observing the benefits of AI algorithms in healthcare setups, which have allowed the easy interpretation of cardiac diagnostics and monitoring results, companies are now focusing on integrating them with implantable monitors. For instance,

• In 2023, BIOTRONIK, a pioneer in implantable medical devices, launched the BIOMONITOR IV implantable cardiac monitor (ICM). It is an implantable cardiac monitor enhanced with artificial intelligence, which harnesses AI and sophisticated detection algorithms to minimize false positive arrhythmia alerts.

These monitors are designed to reduce the detection of any false positive results for arrhythmia conditions, which would allow physicians to map more accurate, proactive, and patient-centric treatment solutions for patients. Hence, as companies come up with advanced AI-enabled implantable cardiac monitors, it represents a significant advancement in cardiac care. Thus, as their adoption increases among healthcare professionals, it would create a great opportunity for the growth & development of the market in the coming years.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/cardiac-ai-monitoring-diagnostics-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:  

• Saudi Arabia Activated Carbon Market projected to reach USD 61.2 million in 2024, with a growth rate of approximately 6.78% CAGR from 2025-2030.
• The Saudi Arabia Data Center Market, valued at USD 1.9 billion in 2024, is expected to grow to USD 3.9 billion by 2030, with a CAGR of 13% from 2025 to 2030.
• Brazil Insecticides Market size is valued at around USD 4.32 billion in 2024& is estimated to grow at a CAGR of around 6.6% during 2025-2030.

Media Contact:

Company Name: MarkNtel Advisors

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081, +91 120 4278433

Website: www.marknteladvisors.com/